$3,304.63 general Payment -- AbbVie Inc to Dr. David Kim

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AbbVie Inc made a $3.3K general payment to David Kim, a Rheumatology specialist in Chicago, IL. The payment was associated with Tagrisso. David Kim received a payment of $3,304.63 from AbbVie Inc. The payment was for services other than consulting, specifically related to Tagrisso. This payment occurred on November 20, 2025, in Chicago, IL.

Patient Guidance: What This Payment Means for You

This information details a payment made to a healthcare provider for services related to a specific drug. It is important to understand how healthcare providers are compensated to ensure transparency in medical decision-making. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for services other than consulting can vary widely within Rheumatology, but this amount should be considered in the context of the services rendered and the typical compensation structures in the specialty.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the CMS Open Payments program, which requires pharmaceutical companies to disclose payments made to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• rheumatology
• drug-payments
• abbvie
• cms-open-payments

Understanding general Payments

general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.

Frequently Asked Questions About This Payment

What was this $3.3K payment for?

This was a general payment of $3.3K from AbbVie Inc to David Kim, categorized as "Compensation for services other than consulting". It was associated with Tagrisso. The payment was reported under the Sunshine Act (CMS Open Payments).

Does David Kim accept pharmaceutical money?

Yes, David Kim received this $3.3K payment from AbbVie Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view David Kim's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this general payment?

A general payment of $3.3K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Rheumatology?

To compare this payment against Rheumatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Rheumatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about David Kim's relationship with AbbVie Inc?

The payment amount is a specific sum, not a range. This $3.3K general payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Rheumatology?

The payment nature is explicitly 'Compensation for services other than consulting'.

What should patients do after learning about this payment?

This information details a payment made to a healthcare provider for services related to a specific drug. It is important to understand how healthcare providers are compensated to ensure transparency in medical decision-making.

What else should I know about this general payment?

The drug associated with the payment is Tagrisso.

Related Reports

• View Dr. David Kim's full payment report
• AbbVie Inc full spending report
• Browse all Rheumatology payments
• Browse all payments in Illinois
• Search for other payments